Carbonyl stress in schizophrenia

Biochemical Society Transactions

Volumn 42, Issue 2, 2014, Pages 468-472

  Itokawa, Masanari ^a   Miyashita, Mitsuhiro ^a   Arai, Makoto ^a   Miyata, Toshio ^b  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation end product (AGE); Carbonyl stress; Glyoxalase I; Pyridoxamine; Schizophrenia

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AGENTS ACTING ON THE PERIPHERAL NERVOUS AND NEUROMUSCULAR SYSTEMS; GLYOXALASE; GLYOXALASE 1; PYRIDOXAMINE; PYRIDOXINE; TM 2002; UNCLASSIFIED DRUG; LACTOYLGLUTATHIONE LYASE;

ARTICLE; GENE MUTATION; GENETIC DISORDER; NEGATIVE SYNDROME; PATHOPHYSIOLOGY; PEDIGREE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA; VITAMIN BLOOD LEVEL; ANIMAL; HUMAN; METABOLISM;

ANIMALS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LACTOYLGLUTATHIONE LYASE; SCHIZOPHRENIA; VITAMIN B 6;

EID: 84896937146     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20140044     Document Type: Article

References (37)

1. Sullivan, P.F., Kendler, K.S. and Neale, M.C. (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 60, 1187-1192 (Pubitemid 37494071)
2. Sullivan, P.F. (2005) The genetics of schizophrenia. PLoS Med. 2, e212
3. Schulz, J.B., Lindenau, J., Seyfried, J. and Dichgans, J. (2000) Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267, 4904-4911 (Pubitemid 30641286)
4. Tosic, M., Ott, J., Barral, S., Bovet, P., Deppen, P., Gheorghita, F., Matthey, M.L., Parnas, J., Preisig, M., Saraga, M. et al. (2006) Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am. J. Hum. Genet. 79, 586-592 (Pubitemid 44384270)
5. Young, J., McKinney, S.B., Ross, B.M., Wahle, K.W. and Boyle, S.P. (2007) Biomarkers of oxidative stress in schizophrenic and control subjects. Prostaglandins Leukot. Essent. Fatty Acids 76, 73-85 (Pubitemid 46217226)
6. Ng, F., Berk, M., Dean, O. and Bush, A.I. (2008) Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int. J. Neuropsychopharmacol. 11, 851-876
7. Thornalley, P.J. (1993) The glyoxalase system in health and disease. Mol. Aspects Med. 14, 287-371
8. Brown, A.S., Bottiglieri, T., Schaefer, C.A., Quesenberry, Jr, C.P., Liu, L., Bresnahan, M. and Susser, E.S. (2007) Elevated prenatal homocysteine levels as a risk factor for schizophrenia. Arch. Gen. Psychiatry 64, 31-39 (Pubitemid 46041736)
9. Frankenburg, F.R. (2007) The role of one-carbon metabolism in schizophrenia and depression. Harv. Rev. Psychiatry 15, 146-160
10. Gilbody, S., Lewis, S. and Lightfoot, T. (2007) Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am. J. Epidemiol. 165, 1-13 (Pubitemid 46026203)
11. Gysin, R., Kraftsik, R., Sandell, J., Bovet, P., Chappuis, C., Conus, P., Deppen, P., Preisig, M., Ruiz, V., Steullet, P. et al. (2007) Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc. Natl. Acad. Sci. U.S.A. 104, 16621-16626 (Pubitemid 350211066)
12. Haidemenos, A., Kontis, D., Gazi, A., Kallai, E., Allin, M. and Lucia, B. (2007) Plasma homocysteine, folate and B12 in chronic schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 1289-1296
13. Levine, J., Stahl, Z., Sela, B.A., Ruderman, V., Shumaico, O., Babushkin, I., Osher, Y., Bersudsky, Y. and Belmaker, R.H. (2006) Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia. Biol. Psychiatry 60, 265-269 (Pubitemid 44093437)
14. Saadat, M., Mobayen, F. and Farrashbandi, H. (2007) Genetic polymorphism of glutathione S-transferase T1: a candidate genetic modifier of individual susceptibility to schizophrenia. Psychiatry Res. 153, 87-91 (Pubitemid 47374820)
15. Yao, J.K., Leonard, S. and Reddy, R. (2006) Altered glutathione redox state in schizophrenia. Dis. Markers 22, 83-93 (Pubitemid 41831607)
16. Kirk, R.L., Theophilus, J., Whitehouse, S., Court, J. and Zimmet, P. (1979) Genetic susceptibility to diabetes mellitus: the distribution of properdin factor B (Bf) and glyoxalase (GLO) phenotypes. Diabetes 28, 949-951 (Pubitemid 10250239)
17. Miyata, T., van Ypersele de Strihou, C., Imasawa, T., Yoshino, A., Ueda, Y., Ogura, H., Kominami, K., Onogi, H., Inagi, R., Nangaku, M. and Kurokawa, K. (2001) Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient. Kidney Int. 60, 2351-2359 (Pubitemid 33070479)
18. Fujimoto, M., Uchida, S., Watanuki, T., Wakabayashi, Y., Otsuki, K., Matsubara, T., Suetsugi, M., Funato, H. and Watanabe, Y. (2008) Reduced expression of glyoxalase-1 mRNA in mood disorder patients. Neurosci. Lett. 438, 196-199
19. Junaid, M.A., Kowal, D., Barua, M., Pullarkat, P.S., Sklower Brooks, S. and Pullarkat, R.K. (2004) Proteomic studies identified a single nucleotide polymorphism in glyoxalase I as autism susceptibility factor. Am. J. Med. Genet. A 131, 11-17 (Pubitemid 39434789)
20. Sacco, R., Papaleo, V., Hager, J., Rousseau, F., Moessner, R., Militerni, R., Bravaccio, C., Trillo, S., Schneider, C., Melmed, R. et al. (2007) Case-control and family-based association studies of candidate genes in autistic disorder and its endophenotypes: TPH2 and GLO1. BMC Med. Genet. 8, 11
21. Politi, P., Minoretti, P., Falcone, C., Martinelli, V. and Emanuele, E. (2006) Association analysis of the functional Ala111Glu polymorphism of the glyoxalase I gene in panic disorder. Neurosci. Lett. 396, 163-166 (Pubitemid 43276433)
22. Ledig, M., Doffoel, M., Ziessel, M., Kopp, P., Charrault, A., Tongio, M.M., Mayer, S., Bockel, R. and Mandel, P. (1986) Frequencies of glyoxalase I phenotypes as biological markers in chronic alcoholism. Alcohol 3, 11-14 (Pubitemid 16143332)
23. Ditzen, C., Jastorff, A.M., Kessler, M.S., Bunck, M., Teplytska, L., Erhardt, A., Krömer, S.A., Varadarajulu, J., Targosz, B.S., Sayan-Ayata, E.F. et al. (2006) Protein biomarkers in a mouse model of extremes in trait anxiety. Mol. Cell. Proteomics 5, 1914-1920 (Pubitemid 44688199)
24. Hovatta, I., Tennant, R.S., Helton, R., Marr, R.A., Singer, O., Redwine, J.M., Ellison, J.A., Schadt, E.E., Verma, I.M., Lockhart, D.J. and Barlow, C. (2005) Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 438, 662-666 (Pubitemid 41740575)
25. Krömer, S.A., Kessler, M.S., Milfay, D., Birg, I.N., Bunck, M., Czibere, L., Panhuysen, M., Pütz, B., Deussing, J.M., Holsboer, F. et al. (2005) Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J. Neurosci. 25, 4375-4384 (Pubitemid 40628782)
26. Arolt, V., Lencer, R., Nolte, A., Müller-Myhsok, B., Purmann, S., Schürmann, M., Leutelt, J., Pinnow, M. and Schwinger, E. (1996) Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease. Am. J. Med. Genet. 67, 564-579
27. Brzustowicz, L.M., Honer, W.G., Chow, E.W., Hogan, J., Hodgkinson, K. and Bassett, A.S. (1997) Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromosome 6p. Am. J. Hum. Genet. 61, 1388-1396 (Pubitemid 28046916)
28. Nurnberger, Jr, J.I. and Foroud, T. (1999) Chromosome 6 workshop report. Am. J. Med. Genet. 88, 233-238 (Pubitemid 29269488)
29. Turner, W.J. (1979) Genetic markers for schizotaxia. Biol. Psychiatry 14, 177-206
30. Arai, M., Yuzawa, H., Nohara, I., Ohnishi, T., Obata, N., Iwayama, Y., Haga, S., Toyota, T., Ujike, H., Arai, M. et al. (2010) Enhanced carbonyl stress in a subpopulation of schizophrenia. Arch. Gen. Psychiatry 67, 589-597
31. Arai, M., Koike, S., Oshima, N., Takizawa, R., Araki, T., Miyashita, M., Nishida, A., Miyata, T., Kasai, K. and Itokawa, M. (2011) Idiopathic carbonyl stress in a drug-naive case of at-risk mental state. Psychiatry Clin. Neurosci. 65, 606-607
32. Steinberg, S., de Jong, S., Mattheisen, M., Costas, J., Demontis, D., Jamain, S., Pietiläinen, O.P., Lin, K., Papiol, S., Huttenlocher, J. et al. (2014) Common variant at 16p11.2 conferring risk of psychosis. Mol. Psychiatry 19, 108-114
33. Shi, J., Levinson, D.F., Duan, J., Sanders, A.R., Zheng, Y., Pe'er, I., Dudbridge, F., Holmans, P.A., Whittemore, A.S., Mowry, B.J. et al. (2009) Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 460, 753-757
34. Stefansson, H., Ophoff, R.A., Steinberg, S., Andreassen, O.A., Cichon, S., Rujescu, D., Werge, T., Pietiläinen, O.P., Mors, O., Mortensen, P.B. et al. (2009) Common variants conferring risk of schizophrenia. Nature 460, 744-747
35. Stefansson, H., Rujescu, D., Cichon, S., Pietiläinen, O.P., Ingason, A., Steinberg, S., Fossdal, R., Sigurdsson, E., Sigmundsson, T., Buizer-Voskamp, J.E. et al. (2008) Large recurrent microdeletions associated with schizophrenia. Nature 455, 232-236
36. Manolio, T.A., Rodriguez, L.L., Brooks, L., Abecasis, G., Ballinger, D., Daly, M., Donnelly, P., Faraone, S.V., Frazer, K., Gabriel, S. et al. (2007) New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nat. Genet. 39, 1045-1051 (Pubitemid 47340660)
37. Kay, S.R. (1990) Positive-negative symptom assessment in schizophrenia: psychometric issues and scale comparison. Psychiatr. Q. 61, 163-178